In the News March 1, 2021

The Pink Sheet | Drug Manufacturers Beg US FDA to Inspect Facilities, but Still Find Difficulties

Cathy Burgess is quoted on COVID-19 safety considerations for Food and Drug Administration inspections.
Cathy L. Burgess
Partner
Phone: +1 202 239 3648
Email: cathy.burgess@alston.com
Related News & Insights
Media Contact
Alex Wolfe
Communications Director
Phone: +1 212.210.9442
Email: alex.wolfe@alston.com
Related Services and Industries:

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.